Annual Shareholders Equity
$6.66 M
+$3.00 M+82.00%
31 December 2023
Summary:
ReShape Lifesciences annual stockholders equity is currently $6.66 million, with the most recent change of +$3.00 million (+82.00%) on 31 December 2023. During the last 3 years, it has fallen by -$7.83 million (-54.01%). RSLS annual shareholders equity is now -91.28% below its all-time high of $76.37 million, reached on 31 December 2017.RSLS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$1.49 M
-$1.55 M-51.00%
30 September 2024
Summary:
ReShape Lifesciences quarterly stockholders equity is currently $1.49 million, with the most recent change of -$1.55 million (-51.00%) on 30 September 2024. Over the past year, it has dropped by -$1.60 million (-51.77%). RSLS quarterly shareholders equity is now -98.12% below its all-time high of $79.22 million, reached on 30 September 2021.RSLS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.0% | -51.8% |
| 3 y3 years | -54.0% | -98.1% |
| 5 y5 years | -79.0% | +109.5% |
RSLS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -85.0% | +82.0% | -98.1% | at low |
| 5 y | 5 years | -85.0% | +82.0% | -98.1% | +109.5% |
| alltime | all time | -91.3% | +1094.5% | -98.1% | +109.5% |
ReShape Lifesciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.49 M(-51.0%) |
| June 2024 | - | $3.04 M(-33.1%) |
| Mar 2024 | - | $4.53 M(-32.0%) |
| Dec 2023 | $6.66 M(+82.0%) | $6.66 M(+116.1%) |
| Sept 2023 | - | $3.08 M(-54.2%) |
| June 2023 | - | $6.74 M(-13.1%) |
| Mar 2023 | - | $7.76 M(+111.9%) |
| Dec 2022 | $3.66 M(-91.7%) | $3.66 M(-82.5%) |
| Sept 2022 | - | $20.94 M(-35.3%) |
| June 2022 | - | $32.36 M(-16.2%) |
| Mar 2022 | - | $38.63 M(-12.9%) |
| Dec 2021 | $44.33 M(+206.0%) | $44.33 M(-44.0%) |
| Sept 2021 | - | $79.22 M(+36.3%) |
| June 2021 | - | $58.12 M(+357.3%) |
| Mar 2021 | - | $12.71 M(-12.3%) |
| Dec 2020 | $14.49 M(-39.9%) | $14.49 M(-15.2%) |
| Sept 2020 | - | $17.08 M(-10.8%) |
| June 2020 | - | $19.15 M(-11.2%) |
| Mar 2020 | - | $21.57 M(-10.5%) |
| Dec 2019 | $24.11 M(-23.9%) | $24.11 M(-253.9%) |
| Sept 2019 | - | -$15.66 M(-217.0%) |
| June 2019 | - | $13.39 M(-53.1%) |
| Mar 2019 | - | $28.57 M(-9.8%) |
| Dec 2018 | $31.66 M(-58.5%) | $31.66 M(-12.2%) |
| Sept 2018 | - | $36.05 M(-7.8%) |
| June 2018 | - | $39.11 M(-40.6%) |
| Mar 2018 | - | $65.87 M(-13.7%) |
| Dec 2017 | $76.37 M(+2498.8%) | $76.37 M(+49.6%) |
| Sept 2017 | - | $51.05 M(+34.3%) |
| June 2017 | - | $38.01 M(+111.8%) |
| Mar 2017 | - | $17.95 M(+510.7%) |
| Dec 2016 | $2.94 M(-20.0%) | $2.94 M(+154.4%) |
| Sept 2016 | - | $1.16 M(-132.0%) |
| June 2016 | - | -$3.61 M(+186.6%) |
| Mar 2016 | - | -$1.26 M(-134.3%) |
| Dec 2015 | $3.67 M | $3.67 M(-52.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $7.74 M(+440.7%) |
| June 2015 | - | $1.43 M(-80.4%) |
| Mar 2015 | - | $7.31 M(+9.8%) |
| Dec 2014 | $6.66 M(-54.6%) | $6.66 M(-36.3%) |
| Sept 2014 | - | $10.47 M(-28.7%) |
| June 2014 | - | $14.67 M(-14.8%) |
| Mar 2014 | - | $17.23 M(+17.4%) |
| Dec 2013 | $14.68 M(+23.6%) | $14.68 M(+18.4%) |
| Sept 2013 | - | $12.40 M(-10.4%) |
| June 2013 | - | $13.84 M(-26.0%) |
| Mar 2013 | - | $18.70 M(+57.5%) |
| Dec 2012 | $11.87 M(-40.7%) | $11.87 M(-29.4%) |
| Sept 2012 | - | $16.81 M(-2.2%) |
| June 2012 | - | $17.19 M(+13.6%) |
| Mar 2012 | - | $15.13 M(-24.5%) |
| Dec 2011 | $20.04 M(-32.5%) | $20.04 M(-26.5%) |
| Sept 2011 | - | $27.27 M(+33.5%) |
| June 2011 | - | $20.43 M(-19.1%) |
| Mar 2011 | - | $25.24 M(-15.1%) |
| Dec 2010 | $29.71 M(+432.3%) | $29.71 M(+420.5%) |
| Sept 2010 | - | $5.71 M(+96.9%) |
| June 2010 | - | $2.90 M(-52.6%) |
| Mar 2010 | - | $6.12 M(+9.7%) |
| Dec 2009 | $5.58 M(-51.1%) | $5.58 M(+66.4%) |
| Sept 2009 | - | $3.35 M(-63.9%) |
| June 2009 | - | $9.29 M(-50.8%) |
| Mar 2009 | - | $18.91 M(+65.8%) |
| Dec 2008 | $11.41 M(-74.8%) | $11.41 M(-33.6%) |
| Sept 2008 | - | $17.17 M(-35.9%) |
| June 2008 | - | $26.80 M(-28.3%) |
| Mar 2008 | - | $37.39 M(-17.4%) |
| Dec 2007 | $45.28 M(+58.5%) | $45.28 M(+248.3%) |
| Sept 2007 | - | $13.00 M(-54.5%) |
| Dec 2006 | $28.57 M(+1347.1%) | $28.57 M(+1347.1%) |
| Dec 2005 | $1.97 M(-394.7%) | $1.97 M |
| Dec 2003 | -$670.00 K | - |
FAQ
- What is ReShape Lifesciences annual stockholders equity?
- What is the all time high annual shareholders equity for ReShape Lifesciences?
- What is ReShape Lifesciences annual shareholders equity year-on-year change?
- What is ReShape Lifesciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly shareholders equity year-on-year change?
What is ReShape Lifesciences annual stockholders equity?
The current annual shareholders equity of RSLS is $6.66 M
What is the all time high annual shareholders equity for ReShape Lifesciences?
ReShape Lifesciences all-time high annual stockholders equity is $76.37 M
What is ReShape Lifesciences annual shareholders equity year-on-year change?
Over the past year, RSLS annual stockholders equity has changed by +$3.00 M (+82.00%)
What is ReShape Lifesciences quarterly stockholders equity?
The current quarterly shareholders equity of RSLS is $1.49 M
What is the all time high quarterly shareholders equity for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly stockholders equity is $79.22 M
What is ReShape Lifesciences quarterly shareholders equity year-on-year change?
Over the past year, RSLS quarterly stockholders equity has changed by -$1.60 M (-51.77%)